Literature DB >> 2557124

Immunocytochemical localization of the GABAA/benzodiazepine receptor in the guinea pig cochlear nucleus: evidence for receptor localization heterogeneity.

J M Juiz1, R H Helfert, R J Wenthold, A L De Blas, R A Altschuler.   

Abstract

Immunocytochemistry with a monoclonal antibody against the GABAA/benzodiazepine receptor showed labeled axo-dendritic synapses in the anteroventral cochlear nucleus. In the dorsal cochlear nucleus, label was seen apposing both axo-somatic and axo-dendritic terminals. The results suggest a heterogeneous distribution of GABA receptors, together with a possible segregation of receptor subtypes between somata and dendrites in certain neurons. The presence of cytoplasmic labeling in some neurons might reflect a higher receptor turnover rate in these neurons.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2557124     DOI: 10.1016/0006-8993(89)91620-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  5 in total

1.  GABA mediates presynaptic inhibition at glycinergic synapses in a rat auditory brainstem nucleus.

Authors:  R Lim; F J Alvarez; B Walmsley
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

2.  Two distinct types of inhibition mediated by cartwheel cells in the dorsal cochlear nucleus.

Authors:  Jaime G Mancilla; Paul B Manis
Journal:  J Neurophysiol       Date:  2009-05-27       Impact factor: 2.714

Review 3.  Brain GABAA receptors studied with subunit-specific antibodies.

Authors:  A L De Blas
Journal:  Mol Neurobiol       Date:  1996-02       Impact factor: 5.590

4.  GABA can improve acoustic contrast in the rat ventral cochlear nucleus.

Authors:  U Ebert; J Ostwald
Journal:  Exp Brain Res       Date:  1995       Impact factor: 1.972

5.  GABAergic and glycinergic inhibitory synaptic transmission in the ventral cochlear nucleus studied in VGAT channelrhodopsin-2 mice.

Authors:  Ruili Xie; Paul B Manis
Journal:  Front Neural Circuits       Date:  2014-07-24       Impact factor: 3.492

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.